Zhao Zhang
Overview:
Dr. Zhang is Assistant Professor of Pharmacology and Cancer Biology. He earned his Ph.D. from University of Massachusetts Medical School in 2014. Skipped PostDoc training, Dr. Zhang established his own research group in 2014 at Carnegie Institution for Science, Department of Embryology, which is affiliated with Johns Hopkins University. In 2019, he was recruited to Duke University as the very first scholar from the Duke Science and Technology program. His lab studies transposons and circular DNA during development and tumorigenesis. His research has been recognized by multiple awards, including NIH Director's Early Independence Award, the Larry Sandler Award from the Genetics Society of America, and Pew Biomedical Scholar.
Positions:
Assistant Professor of Pharmacology and Cancer Biology
Pharmacology & Cancer Biology
School of Medicine
Assistant Professor of Cell Biology
Cell Biology
School of Medicine
Member of the Duke Human Vaccine Institute
Duke Human Vaccine Institute
School of Medicine
Member of the Duke Cancer Institute
Duke Cancer Institute
School of Medicine
Affiliate of the Duke Regeneration Center
Regeneration Next Initiative
School of Medicine
Education:
Ph.D. 2013
University of Massachusetts Medical School
Grants:
Training Program in Developmental and Stem Cell Biology
Administered By
Basic Science Departments
Awarded By
National Institutes of Health
Role
Mentor
Start Date
End Date
Somatic transposition-mediated genome variegation during development, disease and aging conditions
Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date
Regulating and harnessing immunity with junk DNA
Administered By
Pharmacology & Cancer Biology
Awarded By
Pew Charitable Trusts
Role
Principal Investigator
Start Date
End Date
Regulation, function, and impact of developmental retrotransposon activation
Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date
Regulation, function, and impact of developmental retrotransposon activation
Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date
Publications:
Retrotransposon activation during Drosophila metamorphosis conditions adult antiviral responses.
Retrotransposons are one type of mobile genetic element that abundantly reside in the genomes of nearly all animals. Their uncontrolled activation is linked to sterility, cancer and other pathologies, thereby being largely considered detrimental. Here we report that, within a specific time window of development, retrotransposon activation can license the host's immune system for future antiviral responses. We found that the mdg4 (also known as Gypsy) retrotransposon selectively becomes active during metamorphosis at the Drosophila pupal stage. At this stage, mdg4 activation educates the host's innate immune system by inducing the systemic antiviral function of the nuclear factor-κB protein Relish in a dSTING-dependent manner. Consequently, adult flies with mdg4, Relish or dSTING silenced at the pupal stage are unable to clear exogenous viruses and succumb to viral infection. Altogether, our data reveal that hosts can establish a protective antiviral response that endows a long-term benefit in pathogen warfare due to the developmental activation of mobile genetic elements.
Authors
Wang, L; Tracy, L; Su, W; Yang, F; Feng, Y; Silverman, N; Zhang, ZZZ
MLA Citation
Wang, Lu, et al. “Retrotransposon activation during Drosophila metamorphosis conditions adult antiviral responses.” Nat Genet, vol. 54, no. 12, Dec. 2022, pp. 1933–45. Pubmed, doi:10.1038/s41588-022-01214-9.
URI
https://scholars.duke.edu/individual/pub1556486
PMID
36396707
Source
pubmed
Published In
Nat Genet
Volume
54
Published Date
Start Page
1933
End Page
1945
DOI
10.1038/s41588-022-01214-9
Retrotransposons hijack alt-EJ DNA repair process for mobilization and eccDNA biogenesis
Authors
Yang, F; Su, W; Chung, O; Tracy, L; Wang, L; Ramsden, D; Zhang, ZZZ
MLA Citation
Yang, Fu, et al. “Retrotransposons hijack alt-EJ DNA repair process for mobilization and eccDNA biogenesis.” BioRxiv, 2022. Epmc, doi:10.1101/2022.09.25.509424.
URI
https://scholars.duke.edu/individual/pub1550842
Source
epmc
Published Date
DOI
10.1101/2022.09.25.509424
Developmental retrotransposon activation primes host immunity for future viral-clearance
Transposons are thought to be largely suppressed under physiological conditions, ensuring that their mobilization is a rare event. By tracking mobilization, we show that during metamorphosis at the Drosophila pupal stage, the Gypsy retrotransposon selectively mobilizes in regenerating tissues. In the newly formed tissues, this wave of Gypsy activation primes the host’s innate immune system by inducing the production of a nti m icrobial p eptides (AMPs). Moreover, early immune-priming functions of Gypsy are essential for combating viral invasion in adult flies: flies with Gypsy being silenced at the pupal stage are unable to clear viruses and succumb to viral infection. Our data reveal that regulated activation of transposons during animal developmental endows a long-term benefit in pathogen warfare.
Authors
Wang, L; Tracy, L; Zhang, ZZZ
MLA Citation
Wang, Lu, et al. Developmental retrotransposon activation primes host immunity for future viral-clearance. 2020. Epmc, doi:10.1101/2020.08.23.263293.
URI
https://scholars.duke.edu/individual/pub1456205
Source
epmc
Published Date
DOI
10.1101/2020.08.23.263293
Research Areas:
Muser Mentor

Assistant Professor of Pharmacology and Cancer Biology
Contact:
Box 3813 DUMC, Durham,, NC 27710
Box 3813 DUMC, LSRC Building, C Wing, Durham,, NC 27710